Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan/HCTZ 160 mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701

D-1020-2018

July 17, 2018

Class II

Product summary

Firm
RemedyRepack Inc.
Event
Event 80646
Status
Terminated
Classification
Class II
Quantity
4 HDPE 90-count bottles (360 tablets)
Official record key
drug-enforcement:D-1020-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot # B0318652-070617; Exp. 07/18

Distribution pattern: Product was distributed to 3 medical facilities in Florida.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations